Equibles does not estimate personal net worth.
Get an email with a short summary when Adaptive Biotechnologies Corp publishes a filing, an earnings call transcript or a press release.
Get ADPT alertsSusan Bobulsky is recorded as COO at Adaptive Biotechnologies Corp (ADPT). The proxy statement of Adaptive Biotechnologies Corp reports total compensation of $3,547,558 for Susan Bobulsky in fiscal 2025, including a base salary of $435,750. Disclosed compensation is on record for 3 fiscal years. Susan Bobulsky has spoken on 5 earnings calls across 1 company, most recently for Adaptive Biotechnologies Corp on November 4, 2026. Adaptive Biotechnologies Corp is classified in the Diagnostics & Research industry within the Healthcare sector. Other leadership on record at Adaptive Biotechnologies Corp includes Chad Robins (CEO and Board Member), Kyle Piskel (CFO and Chief Accounting Officer), Julie Rubinstein (COO) and 4 others.
“You know, even though we're not providing guidance on 2027, I certainly don't see any reason not to believe that we'll continue to grow at a very high rate in 2027 and beyond.”
“I was stuck on mute here, so I think the question was focused on multiple myeloma and the growth and how we can continue that. Is that fair? We'll just say, yeah.”
“I think a year ago, if you had asked me this question, I would have said, well, the conversations have shifted from, you know, what is MRD? Why should I care? Why should I do this?”
“You know, we were really pleased with the Q4 results, and certainly I think it addressed any questions that folks had about whether there was deceleration in prior quarters.”
“So the NeoGenomics partnership, we've already begun working in earnest with the team, and we expect that it's going to take around 4 months for us to work closely to design and implement the customer experience and the supporting backroom operations that will facilitate delivering clinic tests through NeoGenomics…”
Proxy statement
Start not stated–present
Last confirmed April 24, 2026
Diagnostics & Research · Healthcare
COO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Adaptive Biotechnologies Corp (ADPT) | Chief Commercial Officer, MRD | $435,750 | $3,547,558 |
| 2024 | Adaptive Biotechnologies Corp (ADPT) | Chief Commercial Officer, MRD | $414,583 | $1,706,700 |
| 2023 | Adaptive Biotechnologies Corp (ADPT) | Chief Commercial Officer, MRD | $355,000 | $1,455,155 |
